Breaking News, Collaborations & Alliances

Charles River, Wheeler Bio Partner to Accelerate Discovery to IND Submission

Agreement combines Charles River’s experience in antibody discovery services, safety, and analytics with Wheeler’s Portable CMC platform.

Author Image

By: Charlie Sternberg

Associate Editor

Charles River Laboratories International Inc. has announced a strategic agreement with Wheeler Bio, Inc., an antibody contract development and manufacturing organization (CDMO) focused on preclinical and early clinical supply of recombinant proteins, providing clients access to Wheeler’s Portable CMC (Chemistry, Manufacturing and Controls) platform.   This new alliance intends to provide early-stage biotechnology companies a unique solution to rapidly transition from pre-clinical activities to...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters